MCID: OVR047
MIFTS: 35

Ovarian Cystadenocarcinoma

Categories: Cancer diseases, Endocrine diseases, Reproductive diseases

Aliases & Classifications for Ovarian Cystadenocarcinoma

MalaCards integrated aliases for Ovarian Cystadenocarcinoma:

Name: Ovarian Cystadenocarcinoma 12 15 17 71
Cystadenocarcinoma of the Ovary 12
Cystadenocarcinoma of Ovary 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3605
NCIt 49 C5228
UMLS 71 C1096638

Summaries for Ovarian Cystadenocarcinoma

Disease Ontology : 12 An ovary adenocarcinoma that is characterized by the presence of cysts or cystic spaces.

MalaCards based summary : Ovarian Cystadenocarcinoma, also known as cystadenocarcinoma of the ovary, is related to ovarian mucinous cystadenocarcinoma and cystadenocarcinoma. An important gene associated with Ovarian Cystadenocarcinoma is ZNF217 (Zinc Finger Protein 217), and among its related pathways/superpathways are Gastric cancer and Development ERBB-family signaling. Affiliated tissues include ovary, breast and colon.

Related Diseases for Ovarian Cystadenocarcinoma

Diseases related to Ovarian Cystadenocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 308)
# Related Disease Score Top Affiliating Genes
1 ovarian mucinous cystadenocarcinoma 33.3 SERPINA3 CEACAM5
2 cystadenocarcinoma 31.1 ZNF217 TP53 SERPINA3 MUC1 MIR30A HRAS
3 krukenberg carcinoma 31.1 MUC1 CEACAM5
4 mucinous cystadenocarcinoma 30.9 SERPINA3 MUC1 CEACAM5
5 urachal adenocarcinoma 30.7 KRAS GNAS CEACAM5
6 cystadenoma 30.6 SERPINA3 MUC1 GNAS CEACAM5 BRCA1
7 endocervical adenocarcinoma 30.6 TP53 MUC1 CEACAM5
8 giant cell tumor 30.6 SERPINA3 MUC1 MIR30A
9 serous cystadenocarcinoma 30.5 ZNF217 TP53 MIR30A KRAS HRAS BRCA1
10 ovarian serous carcinoma 30.5 TP53 MIR214 MIR200C KRAS
11 appendix adenocarcinoma 30.5 KRAS HRAS GNAS CEACAM5
12 rectum adenocarcinoma 30.5 TP53 KRAS HRAS CEACAM5
13 small cell carcinoma 30.5 TP53 MUC1 KRAS
14 pseudomyxoma peritonei 30.5 TP53 MUC1 KRAS CEACAM5
15 adenoma 30.4 TP53 MUC1 KRAS GNAS
16 breast adenocarcinoma 30.4 TP53 SERPINA3 KRAS ABCB1
17 mucinous adenocarcinoma 30.4 TP53 MUC1 KRAS CEACAM5
18 adenocarcinoma 30.4 TP53 MUC1 KRAS HRAS GNAS CEACAM5
19 endosalpingiosis 30.4 TP53 MUC1 KRAS BRCA1
20 leiomyosarcoma 30.3 TP53 SERPINA3 MUC1
21 papillary adenocarcinoma 30.1 TP53 MUC1 MIR30A KRAS CEACAM5 BRCA1
22 appendix cancer 30.1 TP53 MUC1 KRAS HRAS GNAS CEACAM5
23 endometrial cancer 29.7 TP53 SERPINA3 MUC1 MIR200C KRAS HRAS
24 ovarian cancer 29.3 ZNF217 TP53 MUC1 MIR30A MIR214 MIR200C
25 ovary adenocarcinoma 28.7 TP53 SERPINA3 RNF43 MUC1 MIR744 MIR30A
26 colorectal cancer 28.3 ZNF217 TP53 RNF43 MUC1 MIR483 MIR30A
27 ovarian serous cystadenocarcinoma 28.3 ZNF217 TP53 SERPINA3 RNF43 MUC1 MIR744
28 ovarian clear cell cystadenocarcinoma 11.4
29 trachea carcinoma in situ 10.6 KRAS HRAS
30 immature teratoma of ovary 10.6 KRAS CEACAM5
31 malignant spiradenoma 10.6 TP53 CEACAM5
32 mucoepidermoid esophageal carcinoma 10.6 TP53 CEACAM5
33 apocrine adenoma 10.6 KRAS CEACAM5
34 nasal cavity adenocarcinoma 10.6 KRAS HRAS
35 descending colon cancer 10.6 KRAS CEACAM5
36 biliary papillomatosis 10.6 MUC1 CEACAM5
37 intrahepatic biliary papillomatosis 10.6 MUC1 KRAS
38 ampulla of vater neoplasm 10.6 KRAS HRAS
39 thyroid gland anaplastic carcinoma 10.6 TP53 MIR30A MIR17
40 periampullary adenoma 10.6 KRAS HRAS
41 vulvar eccrine porocarcinoma 10.6 MUC1 CEACAM5
42 urinary bladder villous adenoma 10.5 MUC1 CEACAM5
43 xanthogranulomatous cholecystitis 10.5 TP53 SERPINA3 CEACAM5
44 breast squamous cell carcinoma 10.5 TP53 HRAS
45 nodular hidradenoma 10.5 MUC1 CEACAM5
46 transverse colon cancer 10.5 KRAS CEACAM5
47 pancreatic acinar cell adenocarcinoma 10.5 SERPINA3 KRAS HRAS
48 signet ring basal cell carcinoma 10.5 KRAS HRAS CEACAM5
49 mucinous intrahepatic cholangiocarcinoma 10.5 MUC1 CEACAM5
50 paronychia 10.5 SERPINA3 KRAS HRAS

Graphical network of the top 20 diseases related to Ovarian Cystadenocarcinoma:



Diseases related to Ovarian Cystadenocarcinoma

Symptoms & Phenotypes for Ovarian Cystadenocarcinoma

Drugs & Therapeutics for Ovarian Cystadenocarcinoma

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Non-invasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis by Quantitative Real Time MEMO-PCR Unknown status NCT02130648

Search NIH Clinical Center for Ovarian Cystadenocarcinoma

Genetic Tests for Ovarian Cystadenocarcinoma

Anatomical Context for Ovarian Cystadenocarcinoma

MalaCards organs/tissues related to Ovarian Cystadenocarcinoma:

40
Ovary, Breast, Colon, Lung, Thyroid, Bone, Appendix

Publications for Ovarian Cystadenocarcinoma

Articles related to Ovarian Cystadenocarcinoma:

(show top 50) (show all 285)
# Title Authors PMID Year
1
Proceedings of the 2019 National Toxicology Program Satellite Symposium. 61
31645210 2019
2
Giant ovarian cystadenocarcinoma in an adult patient, a rare finding in modern times. 61
31308929 2019
3
[The morphological and molecular genetic characteristics of nephroblastomas in immature ovarian teratoma in adult patients]. 61
31626209 2019
4
The diagnostic challenge of ovarian carcinoma in normal-sized ovaries: a report of two cases. 61
30098285 2018
5
A computational framework for complex disease stratification from multiple large-scale datasets. 61
29843806 2018
6
Mucinous cystadenocarcinoma of the breast: the challenge of diagnosing a rare entity. 61
29081926 2017
7
Mucinous cystadenocarcinoma of ovary with metastasis in 14-year-old girl. 61
28344967 2017
8
False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients. 61
28049244 2017
9
Cells redox environment modulates BRCA1 expression and DNA homologous recombination repair. 61
27771433 2016
10
Association mining of mutated cancer genes in different clinical stages across 11 cancer types. 61
27556693 2016
11
IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway. 61
27639718 2016
12
Ovarian carcinoma presenting as cutaneous nasal metastasis. 61
28300910 2016
13
Giant mucinous cystadenocarcinoma of ovary: A case report and review of literature. 61
27134482 2016
14
Pathology in Practice. Concurrent metastatic mammary adenocarcinoma and ovarian cystadenocarcinoma in a jaguar. 61
26517614 2015
15
"Sea anemone-like ciliated tumor cells" in a case of serous cystadenocarcinoma of the ovary. 61
26811576 2015
16
Spontaneous rupture of ovarian cystadenocarcinoma: pre- and post-rupture computed tomography evaluation. 61
26543286 2015
17
Extragenital malignant mixed Mullerian tumor in the incisional hernia - primary carcinosarcoma in the abdominal wall: case report. 61
26012132 2015
18
Krukenberg carcinoma metastasized from stomach resembling mucinous cystadenocarcinoma of the ovary. 61
26259386 2015
19
A weeping umbilical hernia: bilateral ovarian mucinous cystadenoma with disseminated peritoneal adenomucinosis. 61
24855082 2014
20
Metastatic ovarian papillary cystadenocarcinoma to the small intestine serous surface: report of a case of high-grade histopathologic malignancy. 61
24636424 2014
21
A 57-year-old Brazilian woman with a giant mucinous cystadenocarcinoma of the ovary: a case report. 61
24594205 2014
22
Mediastinal recurrence from ovarian cystadenocarcinoma presenting as pleuro-pericardial cyst. 61
25070811 2014
23
A case of Krukenberg carcinoma metastasized from colon cancer resembling mucinous cystadenocarcinoma of the ovary. 61
24427362 2014
24
Calcitriol-mediated hypercalcemia: causes and course in 101 patients. 61
23979953 2013
25
Evaluation of clinico: pathologic findings of breast carcinoma in a general hospital in Southern India. 61
24369200 2013
26
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent. 61
23302520 2013
27
Synchronous papillary cystadenocarcinoma of ovary and squamous cell carcinoma of lower vagina: first report of an unusual chance occurrence. 61
23314878 2013
28
A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. 61
22505474 2012
29
Human telomerase reverse transcriptase expression in ovarian tumors. 61
22771641 2012
30
Involvement of ARLTS1 in chemotherapy and apoptosis in ovarian cancer cell line. 61
21153650 2011
31
Testicular papillary serous cystadenocarcinoma: a rare case report and review of the literature. 61
22355499 2011
32
Hemoperitoneum due to spontaneous rupture of ovarian adenocarcinoma. 61
21221696 2011
33
Consequences of abdominal adenocarcinoma in post-menopausal woman in relation to surgical and non-surgical management. 61
21863621 2011
34
Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carcinoma: a rare association. 61
21546752 2011
35
Peritoneal Malignant Psammomatous Mesothelioma. 61
29147203 2010
36
Ovarian cystadenocarcinoma and pseudomyxoma peritonei. 61
22753161 2010
37
Coexistent intramedullary spinal cord and choroidal metastases in ovarian cancer. 61
20178552 2010
38
Histopathologically proven mucinous cystadenocarcinoma metastatic to the choroid. 61
25390397 2010
39
Serous ovarian cystadenocarcinoma incidentally discovered in a 29-year-old patient: case report. 61
21077487 2010
40
Combined chemotherapy with paclitaxel and carboplatin for mucinous cystadenocarcinoma of the ovary during pregnancy. 61
19205713 2009
41
Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro. 61
18571892 2009
42
Serous cystadenocarcinoma of the ovary in an 11-year-old girl with extensive dissemination and chylothorax: a case report and a brief review of literature. 61
19564753 2009
43
[Expression of ZNF217 in human ovarian cystadenocarcinoma and its clinical significance]. 61
19403395 2009
44
[Effects of ARLTS1 gene on growth and apoptosis of epithelial ovarian cancer SKOV3 cells]. 61
19292033 2009
45
Peritoneal implantations of papillary serous ovarian cystadenocarcinoma 13 days after initial laparoscopic treatment for a presumed benign ovarian cyst. 61
19317271 2009
46
Adenocarcinoma of the abdominal wall. 61
19122935 2008
47
Clinical challenges and images in GI. Gastric metastases of an ovarian cystadenocarcinoma with psammoma bodies. 61
18166345 2008
48
Small cell carcinoma of pulmonary type inside a microinvasive mucinous cystadenocarcinoma of the ovary: a case report. 61
17885493 2007
49
Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. 61
17439664 2007
50
Retroperitoneal lymphangioleiomyoma mimicking ovarian tumor emerging after tamoxifen therapy. 61
17018494 2006

Variations for Ovarian Cystadenocarcinoma

Expression for Ovarian Cystadenocarcinoma

Search GEO for disease gene expression data for Ovarian Cystadenocarcinoma.

Pathways for Ovarian Cystadenocarcinoma

GO Terms for Ovarian Cystadenocarcinoma

Biological processes related to Ovarian Cystadenocarcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.8 TP53 MIR30A KRAS HRAS BRCA1
2 Ras protein signal transduction GO:0007265 9.63 TP53 KRAS HRAS
3 positive regulation of cardiac muscle hypertrophy in response to stress GO:1903244 9.48 MIR214 MIR17
4 miRNA mediated inhibition of translation GO:0035278 9.46 MIR483 MIR30A MIR200C MIR17
5 stem cell proliferation GO:0072089 9.43 RNF43 ABCB1
6 positive regulation of transcription from RNA polymerase II promoter in response to stress GO:0036003 9.37 TP53 MUC1
7 response to isolation stress GO:0035900 9.32 KRAS HRAS
8 negative regulation of lamellipodium assembly GO:0010593 9.26 MIR214 MIR196A1
9 gene silencing by miRNA GO:0035195 9.17 MIR505 MIR483 MIR30A MIR214 MIR200C MIR196A1
10 DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator GO:0006978 9.13 TP53 MUC1 BRCA1

Molecular functions related to Ovarian Cystadenocarcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mRNA binding involved in posttranscriptional gene silencing GO:1903231 9.17 MIR505 MIR483 MIR30A MIR214 MIR200C MIR196A1

Sources for Ovarian Cystadenocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....